Design and in vitro evaluation of an Fc-fusion epitope-based vaccine candidate against Helicobacter pylori

Key Points

• The Fc-fusion epitope-based vaccine candidate shows promising effectiveness against Helicobacter pylori infection.
• Key evidence from in vitro evaluations demonstrates significant immune responses to the vaccine candidate.
• Analysis indicates enhanced stability and immunogenicity of the Fc-fusion vaccine compared to traditional vaccines.
• This development could lead to innovative approaches for preventing Helicobacter pylori-related diseases.